Curative Biotechnology, Inc.
CUBT
$0.0119
$0.00220.20%
OTC PK
| 03/31/2025 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 56.48% | 50.40% | -76.07% | 79.63% | -- |
| Total Depreciation and Amortization | -17.05% | 0.00% | 150.00% | -430.77% | -- |
| Total Amortization of Deferred Charges | -- | 6,478.95% | 66.60% | -- | -- |
| Total Other Non-Cash Items | -93.47% | -96.47% | -54.06% | -100.45% | -- |
| Change in Net Operating Assets | -32.56% | 7,427.91% | -816.11% | 301.89% | -- |
| Cash from Operations | 29.06% | 19.59% | -432.66% | -278.71% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -327.06% | 100.00% | -- |
| Cash from Investing | -- | -- | -327.06% | 80.17% | -- |
| Total Debt Issued | -- | -- | 769.73% | -81.82% | -- |
| Total Debt Repaid | -- | 48.00% | -- | 100.00% | -- |
| Issuance of Common Stock | 138.32% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -57.08% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.48% | -76.05% | 35.73% | 55.83% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 219.45% | -212.10% | -189.13% | -141.18% | -- |